CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Nowe recenzowane badanie potwierdza: innowacyjna technologia znosi czterogodzinny limit w badaniu OB

Data ReadoutpositivePositive
AI Analysis

Summary

ALCOR Scientific's iSED analyzer technology has been confirmed in an independent peer-reviewed study to eliminate the four-hour time constraint in OB (erythrocyte sedimentation rate) testing by demonstrating seven times longer sample stability, improving laboratory logistics and patient care.

Outcome Details

Independent study confirms innovative technology eliminates four-hour limit in OB testing; demonstrates seven times longer sample stability

Importance:6/10
Sentiment:
0.70
laboratory diagnosticssample stabilityESR testingiSED technologypeer-reviewed study

Read the original article

Published by PR Newswire Clinical Trials on September 17, 2026 4:20 PM

Read Original